Moreover, recent studies have shown that supplementation with the IFN-β in a rat model of AD is sufficient to ameliorate microglial activation, reduce ROS and lipid peroxidation, suggesting that IFN-β helps polarize microglia to a phenotype that favors oxidative metabolism (Mudo et al., 2019). This evidence concerns the gene IFNB1 and Alzheimer disease.